View Older Stories View More Recent Stories

Mar 17, 2014 05:53PM After Hours Stock Movers 3/17 (FF) (ATEC) Higher; (KIOR) (OXBT) (JRCC) Lower (more...)

Mar 17, 2014 04:22PM Alphatec (ATEC), OrthoTec Enter Litigation Settlement

Mar 17, 2014 04:21PM Deerfield to Make $50M Investment in Alphatec Spine (ATEC)

Mar 17, 2014 04:05PM Alphatec Holdings and OrthoTec, LLC Mutually Agree to Settle Ongoing Litigation

Mar 11, 2014 10:40AM Deerfield Management Raises Stake in OVASCIENCE (OVAS) to 7.6%

Jan 8, 2014 01:42PM PlacementTracker Publishes 2013 PIPE Market League Tables

Nov 8, 2013 08:07AM Discovery Labs (DSCO) Launches SURFAXIN in U.S.; Now Meets Deerfield Conditions

Oct 1, 2013 10:29AM Prosensa Holding (RNA) Ramps after Hedge Fund Takes Large Stake

Sep 17, 2013 11:11AM SEC Cracks Down on Short Sellers for Manipulation in Advance of Stock Offerings

Jul 1, 2013 09:04AM Mannkind (MNKD) Announces $160M Senior Notes Financing

Feb 14, 2013 01:23PM Unusual 11 Mid-Day Movers 02/14: (STZ) (ART) (ANGI) Higher; (TBAC) (NSPH) (END) Lower

Oct 16, 2012 04:30PM Deerfield Management Raises Stake in InterMune, Inc. (ITMN) to 6.33%

Oct 16, 2012 04:28PM Deerfield Management Raises Stake in Molina Healthcare, Inc. (MOH) to 5.36%

Oct 15, 2012 05:11PM Flynn's Deerfield Management Shows New 5.82% Stake in Questcor Pharmacueticals, Inc. (QCOR)

Jan 11, 2012 08:29AM Arena Pharma (ARNA) About 5% Lower; to Raise ~$33M in Private Offering

Jan 11, 2012 06:12AM Arena Pharma (ARNA) Enters $33M Financing Agreement with Deerfield Management

Apr 18, 2011 08:30AM Cytokinetics (CYTK) Announces $20M of New Financing

Mar 29, 2011 06:44AM Arena Pharma (ARNA) Enters $35.5M Private Placement

Aug 6, 2010 08:03AM Arena Pharma (ARNA) Announces $60M Registered Direct Offering

Jun 21, 2010 09:28AM BioSante Pharma (BPAX) Announces $15M Registered Direct Offering

Jun 7, 2010 10:11AM Hana Biosciences (HNAB) Announces $100M Preferred Private Placement

Jun 3, 2010 08:19AM Arena Pharma (ARNA) Enters $35.5M Common Private Placement with Deerfield Mangement

Jun 3, 2010 07:21AM Exelixis (EXEL) Announces $160M in New Financing Agreements

Mar 9, 2010 10:37AM BioSante Pharma (BPAX) Closes 10.4M Common Registered Direct Offering; $18M in Gross Proceeds

Mar 4, 2010 09:33AM BioSante Pharma (BPAX) to Raise $17.5M in Direct Offering of Common Stock and Warrants

Oct 5, 2009 03:58PM Rockwell Medical (RMTI) Completes $22 Million Offering

Sep 28, 2009 08:06AM Insulet (PODD) Amends Deerfield Credit Facility; Issues 2.855M Shares

Sep 18, 2009 08:27AM Array BioPharma (ARRY) Enters into Equity Distribution Agreement To Sell Up To $25M

Sep 8, 2009 03:58PM NeuroMetrix (NURO) Announces Commitments from Institutional Investors to Buy $18.68M in Common Shares

Jun 17, 2009 08:52AM Arena Pharma (ARNA) Agrees to Receive $100M from Deerfield Management

May 19, 2009 04:07PM Array BioPharma (ARRY) Receives Additional $40 Million Funding Commitment From Deerfield Management

May 13, 2009 09:29AM VIVUS (VVUS) Announces Initiation of Open Label Safety Study for ED

May 5, 2009 04:02PM ZymoGenetics (ZGEN) Reports Smaller-Than-Expected Q1 Loss

Mar 16, 2009 07:12AM Insulet (PODD) Announces $60M Funding Commitment From Deerfield Management

Jan 27, 2009 12:54PM NitroMed (NTMD) Announces Merger Agreement with Deerfield Management

Jan 27, 2009 12:53PM NitroMed (NTMD) Agrees to be Acquired by Deerfield Management for $0.80/Share

Jan 22, 2009 12:55PM Deerfield Management Increases Its Offer For NitroMed (NTMD)

Dec 18, 2008 04:22PM NitroMed (NTMD) Confirms Receipt of Letter from Deerfield Management

Dec 5, 2008 09:50AM Notable Mergers and Acquisitions of the Day 12/05: MER/BAC, NTMD, RSG/AW

Dec 4, 2008 05:35PM NitroMed (NTMD) Receives Acquisition Offer From Deerfield Management

Sep 26, 2008 08:59AM ISTA Pharmaceuticals (ISTA) Receives $65 Million Funding Commitment

Jun 30, 2008 07:16AM ZymoGenetics (ZGEN) Receives $100M Funding Commitment From Deefield

Foghorn Therapeutics Highlights January Equity Financing, Program Progress and Strategic Objectives for 2026

Nkarta Therapeutics Raises $114 Million in Series B Financing to Advance Multiple Programs into Clinical Trials

View More Recent Stories View Older Stories